You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Oxymetholone - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for oxymetholone and what is the scope of freedom to operate?

Oxymetholone is the generic ingredient in one branded drug marketed by Norvium Bioscience and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for oxymetholone.

Summary for oxymetholone
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Raw Ingredient (Bulk) Api Vendors: 37
Clinical Trials: 3
Patent Applications: 3,766
What excipients (inactive ingredients) are in oxymetholone?oxymetholone excipients list
DailyMed Link:oxymetholone at DailyMed
Recent Clinical Trials for oxymetholone

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Boston Children's HospitalPhase 1/Phase 2

See all oxymetholone clinical trials

Medical Subject Heading (MeSH) Categories for oxymetholone

US Patents and Regulatory Information for oxymetholone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Norvium Bioscience ANADROL-50 oxymetholone TABLET;ORAL 016848-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Oxymetholone Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Oxymetholone

Introduction to Oxymetholone

Oxymetholone, commonly known by its trade name Anadrol, is a synthetic anabolic steroid used in both medical and fitness contexts. It is prescribed to treat conditions such as anemia, muscle-wasting disorders, and certain types of osteoporosis. In the fitness industry, it is popular among bodybuilders and athletes for its potent muscle-building properties.

Market Size and Growth

The global oxymetholone powder market is valued at several billion dollars and is anticipated to grow at a healthy rate over the forecast period of 2023-2030. The market is expected to flourish with a Compound Annual Growth Rate (CAGR) of around 4.8% during this period[3].

Driving Factors

Several key factors are driving the growth of the oxymetholone powder market:

Pharmaceutical Applications

Oxymetholone is used to treat anemia and muscle-wasting conditions, such as those associated with AIDS, chemotherapy-induced anemia, and other chronic diseases. The increasing prevalence of these conditions globally is a significant driver of market growth[1][3].

Fitness and Bodybuilding

The drug's popularity among athletes and bodybuilders for its muscle-building and strength-enhancing properties is another major driver. Users report significant muscle gains and improved strength, making it a sought-after supplement in the fitness industry[2][3].

Growing Health and Wellness Awareness

Increasing health consciousness and the demand for fitness supplements are contributing to the market's expansion. As more people engage in fitness activities and seek to enhance their physical performance, the demand for oxymetholone is rising[3].

Research and Development

Ongoing research and development efforts are leading to the creation of purer and safer oxymetholone products, which is further boosting market growth. These advancements are making the drug more appealing to both medical and fitness users[3].

Regional Market Dynamics

North America

North America dominates the global oxymetholone powder market, driven by the strong presence of pharmaceutical manufacturers and a high demand for dietary supplements and personal care products. The region's advanced healthcare infrastructure and high awareness of fitness trends also contribute to its leading position[1][3].

Asia Pacific

The Asia Pacific region is expected to exhibit significant growth during the forecast period. This is due to increasing healthcare awareness, growing demand for nutritional supplements, and the expanding biologics industry in this region[1].

Europe and Other Regions

Europe and other regions such as Latin America and the Middle East & Africa also show substantial growth potential, driven by similar factors including increasing healthcare awareness and fitness trends[1][3].

Challenges and Restraints

Despite the positive growth trajectory, the oxymetholone powder market faces several challenges:

Regulatory Requirements

Stringent government regulatory requirements for the approval of oxymetholone-based medications can limit market growth. These regulations ensure safety but can also delay market entry for new products[1].

Adverse Effects

The use of oxymetholone, especially in high doses, is associated with adverse effects such as liver toxicity, water retention, and other health issues. These safety concerns can deter some potential users and impact market growth[2].

Competitive Landscape

The global oxymetholone powder market is competitive, with several key players:

Major Players

Companies like Pfizer Inc., Balkan Pharmaceuticals, and Global Anabolic are prominent in the market. These companies focus on product quality, compliance with regulatory standards, and continuous innovation to maintain their market position[3].

Product Offerings

Different brands offer oxymetholone products at various price points, catering to different segments of the market. For example, Magnum Pharmaceuticals and Alpha Pharma offer cost-effective options, while Phoenix Remedies provides a more premium product[2].

Financial Trajectory

The financial trajectory of the oxymetholone powder market is promising, with several indicators of growth:

Market Size Forecast

The market is expected to grow significantly over the next few years, driven by increasing demand from both pharmaceutical and fitness sectors. The forecasted CAGR of 4.8% indicates a robust financial outlook[3].

Revenue Streams

Revenue is generated from various segments, including pharmaceutical applications, dietary supplements, and personal care products. The growing demand in these areas is expected to contribute to increased revenue for market players[1][3].

Key Takeaways

  • The global oxymetholone powder market is poised for substantial growth, driven by pharmaceutical applications, fitness and bodybuilding, and growing health awareness.
  • North America leads the market, with Asia Pacific showing significant growth potential.
  • Regulatory requirements and adverse effects are key challenges.
  • Major players focus on product quality and compliance with regulatory standards.
  • The market is expected to grow at a CAGR of around 4.8% during the forecast period.

FAQs

1. What is oxymetholone used for?

Oxymetholone is used to treat conditions such as anemia, muscle-wasting disorders, and certain types of osteoporosis. It is also popular among bodybuilders and athletes for its muscle-building properties.

2. What is the expected growth rate of the oxymetholone powder market?

The global oxymetholone powder market is expected to grow at a CAGR of around 4.8% during the forecast period of 2023-2030.

3. Which region dominates the oxymetholone powder market?

North America currently dominates the global oxymetholone powder market, driven by the strong presence of pharmaceutical manufacturers and high demand for dietary supplements and personal care products.

4. What are the main challenges facing the oxymetholone powder market?

The main challenges include stringent government regulatory requirements and the potential adverse effects associated with the use of oxymetholone, especially in high doses.

5. Who are the key players in the oxymetholone powder market?

Key players include Pfizer Inc., Balkan Pharmaceuticals, and Global Anabolic, among others, which focus on product quality and compliance with regulatory standards.

Cited Sources:

  1. Bizwit Research & Consulting LLP, "Global Oxymetholone Powder Market Size study & Forecast, by..."
  2. DNA India, "Anadrol (Oxymetholone) Information: Dosages, Side Effects..."
  3. MarkWide Research, "Global Oxymetholone Powder Market Expected to Flourish with a CAGR of 4.8% through 2023-2030"

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.